Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity <it>in vitro</it>

by Lowe Henry I C, Watson Charah T, Badal Simone, Toyang Ngeh J, Bryant Joseph
Published 2012-11-01